2023-09-17 08:56:50
Doha: Hamad Medical Corporation (HMC) is preparing to use a new drug for the advanced treatment of breast cancer. The new drug is being used by the HMC National Cancer Care and Research Centre. Breast cancer is one of the leading causes of cancer death globally. A new drug, ENHERTU, offers an innovative treatment opportunity for HER-2 positive metastatic disease. Dr Al Bader, Breast Cancer Clinical Leader and Senior Consultant in Hematology-Oncology, said it is an important drug to treat.
English Summary: Hamad Medical Corporation to use new breast cancer targeted medicine.
1694941807
#Breast #cancer #Qatar #drug
